NRTSF — Nobilis Health Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $153.07m
- $299.72m
Annual cashflow statement for Nobilis Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2013 December 31st | C2014 December 31st | 2015 December 31st | 2016 December 31st | 2017 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 1.42 | 16 | 63.9 | 7.1 | 10.3 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 3.46 | 5.56 | 6 | 4.83 | 7.02 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -2.12 | -19.1 | -42.9 | -22.6 | -14.2 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 3.49 | 4 | 6.71 | 1.57 | 26.4 |
Capital Expenditures | -1.18 | -2.02 | -4.38 | -5.54 | -5.15 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -0.766 | -2.75 | -7.27 | -17.7 | -62.3 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -1.95 | -4.78 | -11.6 | -23.2 | -67.4 |
Financing Cash Flow Items | -4.41 | -6.56 | -15.7 | -9.49 | -7.53 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -0.162 | 2.74 | 13 | 30.6 | 39 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 1.38 | 1.97 | 8.1 | 8.91 | -2.04 |